0001079973-18-000396.txt : 20180615 0001079973-18-000396.hdr.sgml : 20180615 20180615160836 ACCESSION NUMBER: 0001079973-18-000396 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180613 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20180615 DATE AS OF CHANGE: 20180615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPGEN INC CENTRAL INDEX KEY: 0001293818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 061614015 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37367 FILM NUMBER: 18902296 BUSINESS ADDRESS: STREET 1: 708 QUINCE ORCHARD ROAD STREET 2: SUITE 205 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-813-1260 MAIL ADDRESS: STREET 1: 708 QUINCE ORCHARD ROAD STREET 2: SUITE 205 CITY: GAITHERSBURG STATE: MD ZIP: 20878 8-K 1 opgen_8k-061518.htm FORM 8-K



UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
 Securities Exchange Act of 1934
June 13, 2018
Date of Report (Date of earliest event reported)
_________________
OpGen, Inc.
(Exact name of registrant as specified in its charter)
_________________
Delaware
(State or other jurisdiction of incorporation or organization)
  
001-37367
(Commission
File Number)
  
06-1614015
(I.R.S. Employer
 Identification No.)


708 Quince Orchard Road, Suite 205
Gaithersburg, MD 20878
 (Address of principal executive offices, including zip code)

(240) 813-1260
 (Registrant’s telephone number, including area code)

Not Applicable
 (Former name or former address, if changed since last report)
_________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[_]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [X]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   [_] 


Item 5.07   —   Submission of Matters to a Vote of Security Holders.
On June 13, 2018, the Company held its Annual Meeting for 2018.  At the Annual Meeting, the total number of shares represented in person or by proxy was 4,668,695 of the 5,962,996 shares of Common Stock outstanding and entitled to vote at the Annual Meeting as of the record date, April 26, 2018.  The following matters were voted upon at the Annual Meeting:
1. Election of Directors.  The following named persons were elected as Directors of the Company to serve until the next Annual Meeting of Stockholders in 2019 or until their successors are elected and qualified.  The votes cast were as follows:

Nominee

For
Vote
Withheld
     
     
Evan Jones
1,252,867
23,266
Harry J. D'Andrea
1,254,313
21,820
Timothy J.R. Harris, Ph.D., D.Sc.
1,242,749
33,384
Tina S. Nova, Ph.D.
1,254,486
21,647
David M. Rubin, Ph.D.
1,253,625
22,508
Misti Ushio, Ph.D.
1,252,938
23,195
 
2. The vote of the stockholders to ratify the appointment of CohnReznick LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2018, was:
4,628,074 votes
FOR the resolution
     37,814 votes
AGAINST the resolution
       2,807 votes
ABSTAIN

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
OpGen, Inc.
   
By:
  
/s/ Timothy C. Dec
 
 
Name:
  
Timothy C. Dec
 
 
Title:
 
Chief Financial Officer
Date: June 15, 2018